RECORD // Company

Intensity Therapeutics, Inc.

Built 2026-11-22T04:48:00Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (6)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • INTENSITY THERAPEUTICS LLC · Ct business · exact name match to 'INTENSITY THERAPEUTICS, INC.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • INTENSITY THERAPEUTICS, INC. · Ct business · same registered legal name as 'INTENSITY THERAPEUTICS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Intensity Therapeutics, Inc. · Ctgov · same registered legal name as 'INTENSITY THERAPEUTICS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • INTENSITY THERAPEUTICS, INC. · East licences · same registered legal name as 'INTENSITY THERAPEUTICS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • INTENSITY THERAPEUTICS, INC. · East licences · same registered legal name as 'INTENSITY THERAPEUTICS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • INTENSITY THERAPEUTICS, INC. · East licences · same registered legal name as 'INTENSITY THERAPEUTICS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare

2 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-05 · accession 0001567264-26-000066

ItemValuePeriodFormFiledAccessionReport
Net income (loss)$-3,544,0003 months ended 2026-09-3010-Q2026-11-050001567264-26-0000662026-11-22 04:48 UTCReport an error
Cash and cash equivalents$8,494,000at 2026-09-3010-Q2026-11-050001567264-26-0000662026-11-22 04:48 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Revenue, Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001567264
Ticker
INTS
EIN
461488089
Record ID
sx:sec:0001567264

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

19 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-05SEC EDGAR company profile2026-11-22 04:48 UTCReport an error
SIC industry2836 Biological Products, (No Diagnostic Substances)2026-11-05SEC EDGAR company profile2026-11-22 04:48 UTCReport an error
State of incorporationDE2026-11-05SEC EDGAR company profile2026-11-22 04:48 UTCReport an error
Fiscal year end (MMDD)12312026-11-05SEC EDGAR company profile2026-11-22 04:48 UTCReport an error
Business address1 ENTERPRISE DRIVE, SUITE 430, SHELTON, CT, 064842026-11-05SEC EDGAR company profile2026-11-22 04:48 UTCReport an error
ExchangesNasdaq2026-11-05SEC EDGAR company profile2026-11-22 04:48 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-11,606,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 04:48 UTCReport an error
Total assets (at 2025-12-31)$14,101,0002025-12-3110-K, XBRL Assets2026-11-22 04:48 UTCReport an error
Stockholders' equity (at 2025-12-31)$11,876,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 04:48 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$11,921,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 04:48 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-9,233,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 04:48 UTCReport an error
Operating lease liabilities (at 2025-12-31)$110,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 04:48 UTCReport an error
Form D total offering amount (D filed 2024-12-05)$3,649,4832024-12-05D2026-11-22 04:48 UTCReport an error
Form D total amount sold (D filed 2024-12-05)$3,649,4832024-12-05D2026-11-22 04:48 UTCReport an error
Form D industry groupBiotechnology2024-12-05D2026-11-22 04:48 UTCReport an error
Form D revenue rangeDecline to Disclose2024-12-05D2026-11-22 04:48 UTCReport an error
Form D date of first sale2024-11-212024-12-05D2026-11-22 04:48 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-05)On November 5, 2026, Intensity Therapeutics, Inc. (the “Company”) released its financial results for the three and nine months ended September 30, 2026. A copy of the Company’s press release is attached as Exhibit 99.1 to this Form 8-K and incorporated herein by reference. The information in this report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.2026-11-05SEC EDGAR 8-K 0001567264-26-000068 (text as filed, excerpt)2026-11-22 04:48 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-11)On August 11, 2026, Intensity Therapeutics, Inc. (the “Company”) released its financial results for the three and six months ended June 30, 2026. A copy of the Company’s press release is attached as Exhibit 99.1 to this Form 8-K and incorporated herein by reference. The information in this report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.2026-08-11SEC EDGAR 8-K 0001567264-26-000061 (text as filed, excerpt)2026-11-22 04:48 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.